Results from the MagnetisMM-5 study showed that Elrexfio significantly improved progression-free survival, which means ...
Hosted on MSN
Breakthrough cancer therapies raise hopes for cures
Recent advances in cancer treatment are transforming outcomes for patients, from Australia's push to eliminate cervical cancer to breakthroughs in blood and bone marrow cancers. CAR T-cell therapy is ...
A new research paper was published in Volume 17 of Oncotarget on April 28, 2026, titled "Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis ...
It’s a reasonable hope, given the results of that trial, which researchers presented at the American Association for Cancer ...
Multiple myeloma (MM), the second most common hematologic malignancy in the United States, has undergone transformative ...
The goal of treatment for multiple myeloma (MM) is to achieve a deep and sustained response while minimizing treatment-related toxicity and improving quality of life. The treatment may typically ...
How Does Sarclisa Work in Multiple Myeloma? Sarclisa is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by targeting a specific ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results